- Views 3,239
Since last September, scientists working across nine major areas of research have joined as members of the eLife Board of Reviewing Editors (BRE). Reviewing Editors are responsible for handling papers assigned to them by eLife Senior Editors (who are also working scientists), overseeing the online consultation among referees, and delivering clear, consolidated feedback to authors. Our new editors add expertise in Biochemistry, Biophysics and Structural Biology, Cancer Biology, Cell Biology, Developmental Biology and Stem Cells, Genes and Chromosomes, Human Biology and Medicine, Immunology, and Neuroscience.
For the first time, eLife’s new editors include members of our early-career reviewer pool, who have been recommended for a position on the editorial board due to their quality of feedback and reliability.
On joining the editorial board, Beate Lichtenberger (Medical University of Vienna, Austria), said she was
“delighted to join eLife’s Board of Reviewing Editors and to support transparency and collaboration in peer review.”
We’re also happy to welcome back Chris Ponting (University of Edinburgh and a founding member of our team of Senior Editors) and Dawn Teare (University of Sheffield), who have returned to the editorial board as BREs.
Our most recent BREs include:
- Christine Clayton, Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), Germany, Epidemiology and Global Health, and Human Biology and Medicine
- Laura Colgin, The University of Texas at Austin, United States, Neuroscience
- Martin Eilers, University of Würzburg, Germany, Cancer Biology
- José Faraldo-Gómez, National Heart, Lung and Blood Institute, National Institutes of Health, United States, Biochemistry and Chemical Biology, and Biophysics and Structural Biology
- Raymond Goldstein, University of Cambridge, United Kingdom, Biophysics and Structural Biology, and Plant Biology
- Yuichi Iino, University of Tokyo, Japan, Neuroscience
- Leon Islas, Universidad Nacional Autónoma de México, Mexico, Biophysics and Structural Biology
- Matt Kaeberlein, University of Washington, United States, Genes and Chromosomes
- Yamuna Krishnan, University of Chicago, United States, Biophysics and Structural Biology
- Beate Lichtenberger, Medical University of Vienna, Austria, Cancer Biology, and Developmental Biology and Stem Cells
- Thomas Look, Dana-Farber Cancer Institute, United States, Cancer Biology, Genes and Chromosomes, and Human Biology and Medicine
- Jeremy Luban, University of Massachusetts Medical School, United States, Immunology and Inflammation
- Hitoshi Nakatogawa, Kyoto University, Japan, Biochemistry and Chemical Biology, and Cell Biology
- Phillip Newmark, Morgridge Institute for Research, United States, Developmental Biology and Stem Cells, and Microbiology and Infectious Disease
- Timothy O’Leary, Cambridge University, United Kingdom, Neuroscience
- Jody Rosenblatt, University of Utah, United States, Cancer Biology, and Cell Biology
- Kavitha Sarma, Wistar Institute, United States, Biochemistry and Chemical Biology, and Genes and Chromosomes
- Ian Tannock, Princess Margaret Cancer Centre, Canada, Cancer Biology, and Human Biology and Medicine
- Vatsala Thirumalai, National Centre for Biological Sciences, Tata Institute of Fundamental Research, India, Neuroscience
- Elçin Ünal, University of California, Berkeley, United States, Genes and Chromosomes
- Matthew Vander Heiden, Massachusetts Institute of Technology, United States, Cancer Biology, and Human Biology and Medicine
- Xiaochen Wang, Institute of Biophysics, Chinese Academy of Sciences, China, Cell Biology
Five of these were recent members of eLife’s early-career reviewer pool, where reviewers are recommended for their expertise and may have served as principal investigators for up to five years.
To learn more about eLife peer review go to elifesciences.org/about/peer-review
For the latest in published research plus papers available in PDF shortly after acceptance sign up for our weekly email alerts. You can also follow @eLife on Twitter.
For news about eLife’s programs for early-career scientists, sign up for our early-career newsletter or follow @eLifeCommunity on Twitter.